Medical Marijuana: Take Two of These and Call Me in the Morning Medicine or Not In 1972, the US Congress placed marijuana in Schedule I of the Controlled Substances Act because they considered it to have "no accepted medical use." Since then, 16 of 50 US states and DC have legalized the medical use of marijuana ("Procon.org", 2012). Medical marijuana dispensaries are popping up all over the country. Cancer patients use marijuana to ease nausea and to stimulate their appetites. It also treats
Words: 693 - Pages: 3
2003) II. ORGANIZATION & BUSINESS SEGMENTS Company Profile Johnson & Johnson- A most comprehensive health-care firms in the world and most diversified. J&J manufactures health care products for consumer & personal care, pharmaceutical, medical devices and diagnostics markets. It is operating its firms in 57 countries and nearly 200 companies around the world. J&J generates nearly half of its revenues from outside US; through its operating networks and marketing organizations
Words: 3826 - Pages: 16
Medical Marijuana ENG 215 By Medical Marijuana, the use of marijuana for medicinal purposes is an extremely controversial subject. There are many supporters, as well as many that are in opposition to the use of marijuana in any situation. Parties on both sides of the issue are regularly bringing forth new information to endorse their case. Marijuana, made from an Indian hemp plant that bears the name cannabis sativa, is a mixture of stems, leaves, and flowering tops. The flowering tops
Words: 2078 - Pages: 9
safe and effective. This is achieved through the regulation and supervision of food safety, dietary supplements, veterinary products, cosmetics, vaccines, biopharmaceuticals, medical devices, prescription and pharmaceutical drugs that can be purchased over- the- counter. When a pharmaceutical company creates a new drug, it has to go through the FDA and is required to submit a New Drug Application (NDA) to the FDA. The FDA reviews the application to assure that there is an objective proof that the
Words: 877 - Pages: 4
GlaxoSmithKline company profile Francis Weyzig Amsterdam, October 2004 Summary Business description GlaxoSmithKline (GSK) is one of the world’s largest research-based pharmaceutical corporations that discovers, develops, manufactures and markets branded human health products. Headquarters: UK, with additional operational headquarters in the USA Global presence: about 160 countries Primary markets: USA, France, Germany, UK, Italy and Japan Employees: approximately 103,000 GSK key figures
Words: 18642 - Pages: 75
Cracks in the Pharmaceutical Supply Chain http://www.cio.com/article/print/16565 Print Article Close Window From: www.cio.com Cracks in the Pharmaceutical Supply Chain – Susannah Patton, CIO January 15, 2006 As an undercover agent with the Drug Enforcement Administration and the Food and Drug Administration, Aaron Graham saw firsthand how counterfeit drugs can slip into the pharmaceutical supply chain. Graham, now VP and chief security officer for Purdue Pharma, once posed as the
Words: 3359 - Pages: 14
market is unstable and the political context is crucial, we propose a three-part analysis. In the first part, an overview of the chronology of the main events shows that the evolution of the price of ARVs is interlinked with numerous issues of pharmaceutical patent rights. In the second part, we analyse the positions of stakeholders: how they behave in the market and influence market regulations. In the third part, we propose three scenarios which are both simplified interpretations of stakeholders’
Words: 12551 - Pages: 51
com/us/pharma Aspiring giants How small pharmas can drive to $1 billion — and beyond PwC’s PRTM Management Consulting Aspiring giants Executive summary Amid the volatile blend of opportunity and challenge that characterizes the global pharmaceutical industry, only a few small companies have managed to catapult their revenue over the $1 billion mark over the past two decades. Whether they chose to expand their therapeutic area focus and product portfolios, enter new geographies, or grow
Words: 4167 - Pages: 17
Eli Lily & Co History, Development, and Growth of the Company Eli Lilly & Company was founded in 1876 by Colonel Eli Lilly. During the 1880’s Lilly was one of the first companies to invest in Pharmaceutical research by hiring an actual pharmaceutical chemist. In the 1920’s Lilly collaborated on a research effort to purify and isolate insulin for the treatment of diabetes, a fatal disease at that time. This effort resulted in the world’s first commercially available insulin product in 1923
Words: 3703 - Pages: 15
at work Annual Report 2009-10 Contents Management Discussion and Analysis ............................. 01 Directors’ Report ....................... 26 Historical Performance .............. 29 Key Performance Indicators ....... 30 Corporate Information .............. 32 Auditors’ Report ........................ 36 Balance Sheet ............................ 40 Profit and Loss Account ............. 41 Cash Flow Statement ................. 42 Statement Relating to Subsidiary Companies .......
Words: 41744 - Pages: 167
